Inhibition of IgE-mediated histamine release by myosin light chain kinase inhibitors

Biochem Biophys Res Commun. 1992 Feb 28;183(1):48-54. doi: 10.1016/0006-291x(92)91607-r.

Abstract

Wortmannin, a specific inhibitor of myosin light chain kinase (MLCK) blocked IgE mediated histamine release from rat basophilic leukemia cell (RBL-2H3) and human basophils dose-dependently. Its IC50 was 20 nM for RBL-2H3 cells and 30 nM for human basophils. There was complete inhibition at the concentration of 1 microM. Wortmannin inhibited partially the A23187 induced histamine release from RBL-2H3 cells (40% inhibition at 1 microM). This inhibition was not accompanied by any significant effect on cytosolic free calcium concentration [( Ca2+]i). KT5926, another MLCK inhibitor, inhibited histamine release comparably with wortmannin and blocked to some degree the increase of [Ca2+]i in RBL-2H3 cells. Thus, the phosphorylation of myosin seems to be involved in signal transduction through Fc epsilon RI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaloids / pharmacology*
  • Androstadienes / pharmacology*
  • Animals
  • Basophils / metabolism*
  • Calcimycin / pharmacology
  • Calcium / pharmacology
  • Carbazoles*
  • Dose-Response Relationship, Drug
  • Histamine Release / drug effects*
  • Humans
  • Immunoglobulin E / metabolism*
  • Indoles*
  • Leukemia, Basophilic, Acute / metabolism
  • Myosin-Light-Chain Kinase / antagonists & inhibitors*
  • Rats
  • Tumor Cells, Cultured
  • Wortmannin

Substances

  • Alkaloids
  • Androstadienes
  • Carbazoles
  • Indoles
  • KT 5926
  • Immunoglobulin E
  • Calcimycin
  • Myosin-Light-Chain Kinase
  • Calcium
  • Wortmannin